42
Participants
Start Date
April 30, 2012
Primary Completion Date
July 31, 2013
Study Completion Date
July 31, 2013
normal saline
saline 225 ml
ch-mAb7f9
The single doses to be administered in each cohort are 0.2, 0.6, 2, 6, and 20 mg/kg, respectively. Volume to be administered 225 ml
Quintiles Phase 1 Services, Overland Park
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NIH
University of Arkansas
OTHER
InterveXion Therapeutics, LLC
INDUSTRY